logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

BRAF/MEK inhibitor combo shows promise in mutated biliary tract cancer

Researchers suggest testing all patients with biliary tract cancer for BRAFV600E mutations.